se of an Injectable Complex of Beta-Phosphate Granules, Hyaluronate, and Fibroblast Growth Factor-2 on Repair of Fracture with Bone Defects.
Not Applicable
- Conditions
- Fracture with Bone Defects
- Registration Number
- JPRN-UMIN000023208
- Lead Sponsor
- Department of Orthopedic Surgery, Jikei University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
The following will be the key exclusion criteria. Children Malignant tumor present example There is a history of allergy to beta-TCP, hyaluronic acid, and FGF-2 After more than four weeks after the injury open fracture
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method X-ray and CT Evaluation of Bone Union
- Secondary Outcome Measures
Name Time Method